ASCRS’ 2010 Annual Meeting in Minneapolis set new physician and overall attendance records for a non-Tripartite meeting. In total, 2,277 registrants – including 1,375 physicians – took part in the five-day scientific program that featured strong emphasis on genetics-based research.
A wide-range of sessions that tackled topics ranging from rectal cancer treatment advances and healthcare policy in the 21st century, to tailored therapies for colorectal cancer and the surgical management of familial cancer syndromes, were aspects of a scientific program that scored very well, based on post-meeting attendee evaluations.
“Registrants came away with a greater understanding of the application and integration of genetic information to create specific, individualized cancer treatments,” Program Chair Dr. Matthew Mutch, St. Louis, MO, explains. “The genetic makeup of individual tumors is allowing for identification of patients who have the greatest need for adjuvant therapy and who will respond best to specific therapies.”
“Hereditary colorectal cancers account for as many as 10% of all cases in the U.S. There have been significant changes in management strategies as we learn more about these syndromes,” adds Program Vice Chair Dr. Steven Hunt, St. Louis. “It is critically important that colorectal surgeons in general, and ASCRS members in particular, stay informed about the genetics of hereditary colorectal cancer and the application of genetic knowledge to patient care.”
Other highlights included:
Robotic Rectal Dissection Workshop. Called a “smashing success” by Dr. Mutch, this hands-on workshop featured a didactic session and cadaver model to perform a robotic-assisted proctectomy. Registrants also learned patient and robotic setup, the basics of the robot equipment, and review video demonstrations of a robotic rectal dissection.
Health Care Policy in the 21st Century: Where in the World Are We Going? This detailed review featured an evaluation of the crisis in health care reimbursement, assessed the current financial state of CMS, reviewed potential solutions being considered, and educated participants on their roles as advocates.
- Pay for Performance. A review of current and future initiatives, including Core Measures and HSCAPS, NSQIP, and the UK’s use of a national database to track performance, were covered in this symposium led by Drs. Patricia Roberts, Burlington, MA, and James Merlino, Cleveland, OH.
Also in Minneapolis, ASCRS presented the inaugural David Jagelman, MD, Award for Advocacy in Colorectal Cancer to Kristin Tabor, President and Founder, Colon Cancer Coalition and Get Your Rear in Gear (view article here).